BridgeMD
New treatment option for Breast Neoplasms
Official title DFS and QOL After Modified Radical Mastectomy vs. Expanded Mckissock Surgery for EIC of the Breast
ClinicalTrials.gov ID: NCT04052893
What this study is testing
- What it's testing
- Extensive intraductal carcinoma of the breast refers to a type of breast cancer in which ≥ 25% of ductal carcinoma in situ is present in invasive tumors and there is a scattered distribution of ductal carcinoma in situ (DCIS) in or around the invasive carcinoma. Compared with DCIS negative for extensive intraductal component, DCIS positive for extensive intraductal component is not sensitive to radiotherapy.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 45 to 75, women only
You may be able to join if
- Patients with extensive intraductal carcinoma confirmed by hollow needle biopsy;
- the lesion not involving the nipple as confirmed by enhanced MR imaging of the breast;
- Bra cup size: B or higher;
- postmenopausal patients;
- provision of written informed consent.
You likely can't join if
- The cutting edge of nipple-areola complex tested positive for extensive intraductal carcinoma twice;
- preoperative nipple hemorrhage;
- bilateral breast cancer;
- inflammatory breast cancer;
- distant metastasis;
- other cancers or those who receive chest radiotherapy.
The study team makes the final eligibility decision.
Where it's taking place
- Benxi, Liaoning, China
- Shengyang, Liaoning, China
- Shenyang, Liaoning, China
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling female, 45 years to 75 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Benxi, Liaoning, China; Shengyang, Liaoning, China; Shenyang, Liaoning, China. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.